Drawing for RESULTS IN MINUTES

USPTO serial 90266823

RESULTS IN MINUTES

Reviewed by CopyMark Law Group

Reg. 6472902Status 700Renewal
Filing date
Status date
Registration date
Aug 31, 2021
Examiner
THOMPSON, HEATHER
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RESULTS IN MINUTES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David Newman

David Newman Mahamedi IP Law LLP910 Campisi Way, Suite 1E9Campbell, CA 95008

Goods and services

ClassDescriptionStatusFirst use
044Medical diagnostic testing servicesACTIVEOct 20, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 31, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 31, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 31, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 15, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 15, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 15, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 31, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 27, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 26, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 7, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 7, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 24, 2021IUAFUSE AMENDMENT FILED—
Jun 24, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 22, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 27, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 27, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 7, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 22, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 19, 2021DOCKASSIGNED TO EXAMINER—
Dec 8, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 23, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance